Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of the European Academy of Dermatology and Venereology |
Vol/bind | 34 |
Udgave nummer | 12 |
Sider (fra-til) | e852-e853 |
ISSN | 0926-9959 |
DOI | |
Status | Udgivet - 2020 |
Bibliografisk note
Funding Information:This work was an investigator‐initiated project and was not supported by any financial means. CCZ has received honoraria from AbbVie, Bayer Healthcare, Biogen, and PPM for participation as an advisor and speaker, from Allergan, Almirall, Celgene, GSK, Incyte, Idorsia, Inflarx, Janssen, Novartis, Regeneron and UCB for participation as an advisor, and from Jenapharm, Pierre Fabre and Sobi for participation as a speaker. His departments have received grants from AbbVie, AOTI, AstraZeneca, Biogen, Celgene, Dr. Reddy’s, Galderma, Inflarx, Novartis, and UCB for his participation as an investigator. VdM has received honoraria as a consultant for AbbVie, Sanofi and BMS. GBEJ has received honoraria from AbbVie, ChemoCentryx, Coloplast, Incyte, Inflarx, Novartis, Pierre Fabre and UCB for participation on advisory boards, and grants from AbbVie, Leo Pharma, Janssen‐Cilag, Regeneron, Sanofi, AstraZeneca and Novartis for participation as an investigator, and received speaker honoraria from AbbVie, Boehringer‐Ingelheim, Galderma and MSD. He has also received unrestricted grants from AbbVie, Leo Pharma and Novartis. ACK and EP declare no competing interests. EJG‐B has received honoraria from AbbVie, Abbott, Biotest, Brahms, InflaRx, MSD, XBiotech and Angelini; independent educational grants from AbbVie, Abbott, Astellas, Axis Shield, bioMérieux, InflaRx, the Medicines Company and XBiotech; and funding from the FrameWork 7 programme HemoSpec (granted to the National and Kapodistrian University of Athens), and the Horizon2020 Marie‐Curie Project European Sepsis Academy (granted to the National and Kapodistrian University of Athens).
Funding Information:
We thank Mr. Marc Somja, EADV employee for his help for the organization of the EADV School on HS. The Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Dessau, Germany; the Dermatology Department, Erasme Hospital, Universit? Libre de Bruxelles, Brussels, Belgium; the Department of Dermatology, Zealand University Hospital, Roskilde, Denmark; and the Department of Dermatology, Erasmus University Medical Center, Rotterdam, Netherlands are health care units of the European Reference Network for Rare and Complex Skin Diseases (ERN Skin).